CADL 8-K 2026-09-10

Candel Therapeutics, Inc. (CADL) 8-K dated 2026-09-10 — accession 0001193125-26-387310. This URL is the filing, not the CADL hub.

Candel Therapeutics, Inc. (CADL) is a biotechnology company listed on NASDAQ.

Candel Therapeutics, Inc. filed a 8-K on 2026-09-10. Accession 0001193125-26-387310.

Cached items: 5.02, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CADL revenue for 2022-12-31 was $125.0K. Net income was -$18.8M. CADL currently screens at market cap $592.0M.

Not investment advice. The CADL SEC hub lists recent forms. The stock page is the research view.